Recently preoperative neural network software including mpMRI variables, PSA level and GS has been reported to predict insignificant prostate cancer, particularly in the context of clinically non-palpable tumors, suggesting a prognostic and pathologic predictive role in clinically very low risk PCa[12]. This evidence concerns the gene KLK3 and prostate carcinoma.